Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coeptis Therapeutics Hldgs Inc (NQ: COEP )

1.830 +0.120 (+7.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,255,306
Open 1.860
Bid (Size) 1.800 (6)
Ask (Size) 1.830 (3)
Prev. Close 1.710
Today's Range 1.720 - 1.900
52wk Range 1.030 - 12.13
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
Via Benzinga
How the Internet Turned Us Into Horrible Investors
Painful investment losses help us avoid future mistakes. But what happens when the internet stops that feedback? 
Via InvestorPlace

Performance

YTD
-7.66%
-7.66%
1 Month
+17.99%
+17.99%
3 Month
+18.06%
+18.06%
6 Month
+0.55%
+0.55%
1 Year
-71.85%
-71.85%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
Via Benzinga
Potential acquisition of VyGen-Bio would Strengthen Coeptis Therapeutics (NASDAQ: COEP) oncology pipeline by obtaining exclusive, worldwide ownership rights to GEAR™ Platform
Via Get News
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
Via Get News
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
Via Viz Release
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Near Intelligence (NIR) Stock Down 17% Today?
Via InvestorPlace
Why Is NuCana (NCNA) Stock Down 36% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is First Republic Bank (FRC) Stock Up 29% Today?
Via InvestorPlace
Why Is Coeptis Therapeutics (COEP) Stock Up 14% Today?
Via InvestorPlace
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
BioMedNewsBreaks – Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP) Tech Spotlighted in Article in Peer-Reviewed Translational Medicine Journal
Via Investor Brand Network
Translational Medicine Journal Features Multi-Antigen CAR T Technology, Cell Therapy, and In Vitro Diagnostics with Multiple Cancer Types: Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP)
Via Get News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP) to Collaborate with the University of Pittsburgh to expand pre-clinical Development of SNAP-CAR T Cells Targeting HER2-Positive Cancers
Via Get News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP) to Collaborate with the University of Pittsburgh to expand pre-clinical Development of SNAP-CAR T Cells Targeting HER2-Positive Cancers
Via Viz Release
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.